Minimum important difference between patients with rheumatoid arthritis: the patient's perspective.

GA Wells, P Tugwell, GR Kraag, PR Baker… - The Journal of …, 1993 - europepmc.org
Objective To determine the point at which differences in clinical assessment scores on
physical ability, pain and overall condition are sufficiently large to correspond to a subjective …

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis

…, A Chalmers, AV Klinkhoff, JM Esdaile, GR Kraag - The Lancet, 1990 - Elsevier
144 patients with severe rheumatoid arthritis from six centres were randomised to receive
oral cyclosporin or placebo for 6 months. The initial daily dose of cyclosporin was 2·5 mg/kg, …

The effect of low dose methotrexate on bone density.

…, GA Wells, DS Ooi, ND Kanigsberg, GR Kraag… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: High dose methotrexate (MTX) has been linked with bone loss in oncology
patients. However, it is unclear whether longterm low dose MTX used in the treatment of …

A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster …

…, A Chalmers, PM Ford, WF Kean, GR Kraag… - The Journal of …, 1994 - europepmc.org
Objective To compare signal versus aggregate measurement strategies using the VA3. 0S
version of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis (OA) Index…

Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis.

…, DN Preston, J Bormanis, MS Green, GR Kraag - Stroke, 1985 - Am Heart Assoc
… There was a grade 3/6 ejection systolic murmur at the base of the heart radiating up the
neck and a grade 2/6 early diastolic blowing murmur at the left sternal border. There was no …

A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis

…, JM Bartlett, R Knight, GR Kraag… - Pain Research and …, 2008 - hindawi.com
… Patients assessed as having an OA grade of 2 or 3 on their study joint made up 94.5% of
randomly assigned patients. Twenty-five patients withdrew after random assignment (15 due to …

A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.

…, A Chalmers, PM Ford, WF Kean, GR Kraag… - The Journal of …, 1993 - europepmc.org
Objective To conduct the first Canadian study of the comparative efficacy and safety of
tenoxicam and diclofenac in patients with primary osteoarthritis (OA) of the knee. Methods …

Radiological articular involvement in the dominant hand in rheumatoid arthritis.

…, A Kundi, JN Whitehead, GR Kraag… - Annals of the …, 1980 - ard.bmj.com
… 5, grade 0 being normal, grade 1 slight changes, grade 2 definite changes, grade 3 minimum
destructive changes, grade 4severe destructive changes, and grade 5 mutilating changes. …

The first recorded case of osteitis fibrosa cystica.

WW Buchanan, GR Kraag, DG Palmer… - Canadian Medical …, 1981 - ncbi.nlm.nih.gov
In an extensive pathological collection in the Royal Infirmary at the University of Glasgow,
there are a large number of bone and joint specimens of considerable interest1. One of these, …

A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.

…, A Beaulieu, KA Siminovitch, GR Kraag… - The Journal of …, 1995 - europepmc.org
Objective To conduct the first Canadian study of the comparative efficacy and safety of
nabumetone and diclofenac SR in patients with primary osteoarthritis (OA) of the hip, knee and …